Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2017
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms EXTYPE-1
- 25 Jul 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 27 Mar 2017 Planned End Date changed from 1 Feb 2017 to 1 Jun 2017.